Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

May 15, 2026

Study Completion Date

May 15, 2026

Conditions
Dermatitis, AtopicDermatitisEczemaSkin DiseasesImmune System DiseasesJanus Kinase Inhibitors
Trial Locations (8)

100

RECRUITING

NTUH, Taipei

333

NOT_YET_RECRUITING

Chang Gung Hospital Linkou, Taoyuan District

10449

NOT_YET_RECRUITING

MacKay Memorial Hospital, Taipei

11217

NOT_YET_RECRUITING

Taipei Veterans General Hospital, Taipei

23561

NOT_YET_RECRUITING

Taipei Medical University - Shuang Ho Hospital, New Taipei City

83301

RECRUITING

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung City

807377

NOT_YET_RECRUITING

Kaohsiung Medical University Hospital, Kaohsiung City

11490, R.O.C.

NOT_YET_RECRUITING

Tri-Service General Hospital, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY